- Womens health - haematological malignancies
- Diagnostic technologies
- Hepatitis C
- Renal disease
- Pain managment
- Chronic diseases
- Coronary heart disease
Research Led, Analysis Driven, Real World Perspective
In early 2011 the College of Human and Health Sciences, at Swansea University, established a Centre for Health Economics - in response to the demand for health economics and outcomes research. The Centre, which was led by Professor Ceri Phillips, provided consultancy and research services to health organisations in both the private and public sector.
At the end of 2011 the Centre acquired Cardiff Research Consortium (CRC) - a health economics research consultancy that was originally part of the Capita Group PLC. The acquisition of CRC allowed the Centre to quickly develop and expand; resulting in the formal launch of the newly named Swansea Centre for Health Economics (SCHE).
With a skill set that is unique in the UK, SCHE combines significant qualitative skills, expertise in real world data mining and analysis and health policy. We are ideally placed to undertake research and consultancy services for organisations engaged in the development and delivery of health care interventions and services.
Here at SCHE we have an understanding of, and strong relationships with, health care decision making across a wide therapeutic base - including clinical specialists, academics, healthcare management, and within HTA agencies. These relationships allow us to integrate the medical and management perspectives of healthcare delivery into projects; thus providing relevance to outputs, publications and service provision activities.
SCHE has a wealth of experience and expertise within the team, with staff undertaking commissioned work on the evaluation of programmes and interventions for a range of organisations, including: -
- The World Health Organisation
- Welsh Government
- Department of Health
- Department of Work and Pensions
- A range of social care authorities and pharmaceutical companies
This has been backed by an extensive portfolio of publications in the fields of health economics and health and social policy, along with bespoke reports for companies and agencies that, in many cases, have informed submissions to NICE and other assessment agencies for technology appraisal.